SCHEMBL20205337

SCHEMBL20205337

CC1(C)c2cc(-c3cccc(-c4ccccc4)c3)c3c(oc4ccccc43)c2-c2ccc3c(c21)C(C)(C)c1cc(-c2cccc(-c4ccccc4)c2)c2c(oc4ccccc42)c1-3

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDC14B O60729 2/20 0.36
▸ CDC14A Q9UNH5 2/20 0.36
▸ PLA2G2A P14555 3/20 0.35
▸ PLA2G4A P47712 3/20 0.35
▸ ALOX5 P09917 2/20 0.34
▸ PLA2G10 O15496 1/20 0.33
▸ PRKDC P78527 1/20 0.31
▸ MEN1 O00255 2/20 0.31
▸ KMT2A Q03164 2/20 0.31
▸ CSF1R P07333 1/20 0.31
▸ PDGFRB P09619 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ KIT P10721 1/20 0.31
▸ FLT3 P36888 1/20 0.31
▸ HDAC6 Q9UBN7 1/20 0.31
▸ CYP1B1 Q16678 2/20 0.31
▸ GABRP O00591 1/20 0.31
▸ GABRD O14764 1/20 0.31
▸ NPC1 O15118 1/20 0.31
▸ CA12 O43570 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23351578 0.97 CDC14B (0.34) CDC14BCDC14APLA2G2APLA2G4AALOX5
SCHEMBL20205384 0.95 CDC14B (0.36) CDC14BCDC14APLA2G2APLA2G4AALOX5
SCHEMBL20205381 0.94 CDC14B (0.39) CDC14BCDC14APLA2G2APLA2G4AALOX5
SCHEMBL20205336 0.94 CDC14B (0.40) CDC14BCDC14AALOX5MEN1KMT2A
SCHEMBL20205666 0.94 PLA2G2A (0.34) CDC14BCDC14APLA2G2APLA2G4AALOX5
SCHEMBL20205710 0.92 CDC14B (0.34) CDC14BCDC14APLA2G2APLA2G4AALOX5
SCHEMBL24649724 0.92 CDC14B (0.33) CDC14BCDC14APLA2G2APLA2G4AALOX5
SCHEMBL23351982 0.92 CDC14B (0.36) CDC14BCDC14APLA2G2APLA2G4AALOX5
SCHEMBL20205309 0.92 PLA2G2A (0.36) CDC14BCDC14APLA2G2APLA2G4AALOX5
SCHEMBL20205405 0.91 PLA2G2A (0.32) CDC14BCDC14APLA2G2APLA2G4AALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) MERCK PATENT GMBH (DE) 2022-09-27 — — US disclosed
EP-3544985-B1 BISBENZOFURAN-FUSED INDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) MERCK PATENT GMBH (DE) 2021-05-12 — — EP disclosed
WO-2018095940-A1 BISBENZOFURAN-FUSED INDENO[1,2-B]FLUORENE DERIVATIVES AND RELATED COMPOUNDS AS MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES (OLED) MERCK PATENT GMBH (DE) 2018-05-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11453680-B2 Bisbenzofuran-fused indeno[1,2-B]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLED) OCIAD2, OCIAD1, JUND CDC14B 3977/4885CDC14A 4435/4885PLA2G2A 1854/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback